{"id":816814,"date":"2025-02-24T10:44:15","date_gmt":"2025-02-24T15:44:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/"},"modified":"2025-02-24T10:44:15","modified_gmt":"2025-02-24T15:44:15","slug":"editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/","title":{"rendered":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Feb.  24, 2025  (GLOBE NEWSWIRE) &#8212; Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q4\/Full Year 2024 financial results and business updates on March 5 via press release and SEC filings. The Company does not plan to host quarterly financial results conference calls moving forward.<\/p>\n<p>Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>TD Cowen 45th Annual Health Care Conference <\/strong><br \/>\n          <br \/>Format: Fireside Chat<br \/>Date: Monday, March 3<br \/>Time: 2:30 p.m. ET<br \/>Location: Boston, MA<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Leerink Partners Global Healthcare Conference<\/strong><br \/>\n          <br \/>Format: Fireside Chat<br \/>Date: Monday, March 10<br \/>Time: 9:20 a.m. ET<br \/>Location: Miami, FL<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Barclays 27th Annual Global Healthcare Conference<\/strong><br \/>\n          <br \/>Format: Fireside Chat<br \/>Date: Tuesday, March 11<br \/>Time: 9:00 a.m. ET<br \/>Location: Miami, FL<\/li>\n<\/ul>\n<p>To access the live webcasts of Editas Medicine\u2019s presentations, please visit the \u201cInvestors\u201d section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=49EJbOAjrYe1qL_6jGkzuum6PjPVg1Np_43jtbprvWI2ab3xAiHRFU-jhCy36i_eWDsAXoByM0uXH_KEcGBwl_z6q1ml0QBrlc6usNVDbE8=\" rel=\"nofollow\" target=\"_blank\">www.editasmedicine.com<\/a>. An archived replay will be available for approximately 30 days following each event.<\/p>\n<p>\n        <strong>About\u00a0<\/strong><br \/>\n        <strong>Editas Medicine<\/strong><br \/>\n        <br \/>As a pioneering gene editing company, Editas Medicine is focused on translating the power and potential of the CRISPR\/Cas12a and CRISPR\/Cas9 genome editing systems into a robust pipeline of transformative <em>in vivo <\/em>medicines for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize durable, precision <em>in vivo <\/em>gene editing medicines for a broad class of diseases. Editas Medicine is the exclusive licensee of Broad Institute\u2019s Cas12a patent estate and Broad Institute and Harvard University\u2019s Cas9 patent estates for human medicines. For the latest information and scientific presentations, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=49EJbOAjrYe1qL_6jGkzuum6PjPVg1Np_43jtbprvWIflvW8OjZufEn8wErJQM9Zy4JZ43M9YskSpc3NACgFJTTd9Tw6tHNlfU7bWz0C4bc=\" rel=\"nofollow\" target=\"_blank\">www.editasmedicine.com<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTYxNzlkZDYtOThmYy00NTJhLTg4YTYtMzk4ZmYxNjU2NTM4LTEwMzc1OTk=\/tiny\/Editas-Medicine-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Media and Investor Contact:\r\nir@editasmed.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q4\/Full Year 2024 financial results and business updates on March 5 via press release and SEC filings. The Company does not plan to host quarterly financial results conference calls moving forward. Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: TD Cowen 45th Annual Health Care Conference Format: Fireside ChatDate: Monday, March 3Time: 2:30 p.m. ETLocation: Boston, MA Leerink Partners Global Healthcare Conference Format: Fireside ChatDate: Monday, March 10Time: 9:20 a.m. ETLocation: Miami, FL Barclays 27th Annual Global Healthcare Conference Format: Fireside &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816814","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q4\/Full Year 2024 financial results and business updates on March 5 via press release and SEC filings. The Company does not plan to host quarterly financial results conference calls moving forward. Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: TD Cowen 45th Annual Health Care Conference Format: Fireside ChatDate: Monday, March 3Time: 2:30 p.m. ETLocation: Boston, MA Leerink Partners Global Healthcare Conference Format: Fireside ChatDate: Monday, March 10Time: 9:20 a.m. ETLocation: Miami, FL Barclays 27th Annual Global Healthcare Conference Format: Fireside &hellip; Continue reading &quot;Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T15:44:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Editas Medicine to Announce Fourth Quarter\\\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March\",\"datePublished\":\"2025-02-24T15:44:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/\",\"name\":\"Editas Medicine to Announce Fourth Quarter\\\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\",\"datePublished\":\"2025-02-24T15:44:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Editas Medicine to Announce Fourth Quarter\\\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/","og_locale":"en_US","og_type":"article","og_title":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it plans to announce Q4\/Full Year 2024 financial results and business updates on March 5 via press release and SEC filings. The Company does not plan to host quarterly financial results conference calls moving forward. Additionally, Editas Medicine management will participate in the following upcoming investor conferences in March: TD Cowen 45th Annual Health Care Conference Format: Fireside ChatDate: Monday, March 3Time: 2:30 p.m. ETLocation: Boston, MA Leerink Partners Global Healthcare Conference Format: Fireside ChatDate: Monday, March 10Time: 9:20 a.m. ETLocation: Miami, FL Barclays 27th Annual Global Healthcare Conference Format: Fireside &hellip; Continue reading \"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-24T15:44:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March","datePublished":"2025-02-24T15:44:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/"},"wordCount":289,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/","name":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=","datePublished":"2025-02-24T15:44:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM4MzEwNiM2Nzc0MjE2IzIwMjYwMjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/editas-medicine-to-announce-fourth-quarter-full-year-2024-financial-results-and-to-participate-in-investor-conferences-in-march\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Editas Medicine to Announce Fourth Quarter\/Full Year 2024 Financial Results and to Participate in Investor Conferences in March"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816814"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816814\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}